premargin

Element List	Explanation
Introduction	Arabian International Healthcare Holding Company (“Tibbiyah”) announces that it has signed a conditional share purchase agreement on 20th Nov 2025 to acquire 49% of Nephrocare Health Services Saudi Arabia Company, where such company will constitute the partnership between Tibbiyah and NephroPlus in the field of renal care. Accordingly, the joint venture will not incorporate a new company as previously planned and announced.
Transaction Details	to acquire 49% of Nephrocare Health Services Saudi Arabia Company
Transaction Amount	SAR 279,829
Transaction Conditions	The agreement is subject to several conditions precedent prior to the completion of the shares transfer which is the subject matter of the transaction, including—without limitation—obtaining all required regulatory approvals within the Kingdom of Saudi Arabia, in addition to other commercial and regulatory conditions.
Parties of the Transaction	Buyer: Arabian International Healthcare Holding Company (“Tibbiyah”) Seller: Nephrocare Health Services International Pte Ltd – Singapore Guarantor: Nephrocare Health Services Limited – India
Transaction Financing Method	Funded through the Company’s own resources
Date of Entering Into The Transaction	2025-11-20 Corresponding to 1447-05-29
Description of Activity of The Asset Subject of The Transaction	The business consists of operating dialysis centers that provide comprehensive care for chronic kidney failure patients. This includes running fully equipped dialysis facilities, delivering high-quality dialysis sessions, and providing end-to-end patient management through nursing, medical, and support services, applying best practices to ensure safety and quality of care.
Financial Statements for the Last Three Years of the Asset forming the Subject Matter of the Transaction	The company was established on 4 January 2023. Its revenues were as follows: • Year 2023: None • Fiscal Year 2024: SAR 160,000
Transaction reasons	Tibbiyah is pursuing this transaction to advance its partnership with NephroPlus, the largest dialysis network in Asia and the world’s seventh largest, known for its high-quality operating model and integrated dialysis services. This partnership enables Tibbiyah to introduce a proven global model into the Saudi market, improve care quality and patient outcomes, and strengthen its position in a rapidly growing healthcare segment.
Expected Impact of the Transaction on the Company and Its Operations	It is expected that the financial impact of this deal will appear by the end of the fiscal year 2026.
Related Parties	None
Additional Information	https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=75783&anCat=1&cs=9530&locale=en

Arabian International Healthcare Holding Co. Announces acquiring 49% of Nephrocare Health Services Saudi Arabia Company